Keebler Health Raises $6M to Transform Risk Adjustment with AI-Powered Platform

What You Should Know: 

– Keebler Health, a provider of AI-native risk adjustment solutions for healthcare providers, today announced a $6 million seed funding round led by Freestyle Capital with participation from MBX Capital, New Stack Ventures, and others. 

– The investment will support the company’s rapid growth and accelerate its product development roadmap.  

AI Risk Adjustment for Healthcare Providers

Keebler Health’s platform addresses a critical need in the healthcare industry: accurate and efficient risk adjustment. As the U.S. healthcare system shifts towards value-based care (VBC), providers are increasingly responsible for managing the total cost of care for their patients. This requires accurate risk adjustment to ensure appropriate reimbursement from payers and financial stability for practices.  

Traditional risk adjustment methods rely on manual chart reviews, which are time-consuming, costly, and often limited in scope. Keebler Health’s AI-powered platform automates this process, enabling providers to:

• Reduce administrative burden: Eliminate manual chart reviews and streamline risk adjustment workflows.
• Improve accuracy: Leverage AI to identify and capture more disease burden, leading to more accurate risk scores and optimized reimbursement.  
• Enhance efficiency: Analyze 100% of patient records in near real-time, compared to the limited sample sizes of manual reviews.
• Increase revenue: Optimize reimbursement from payers and improve financial performance.

Experienced Leadership Team

Keebler Health’s leadership team brings together expertise in technology, operations, and clinical care. The co-founders, Park, Andrew Stickney, and Kevin Hill, have a shared passion for leveraging AI to improve healthcare delivery and support providers in a value-based care environment

“Keebler’s platform can ingest massive amounts of data in almost any form – from handwritten notes to images – and fully process it with AI to find emerging conditions that human clinicians may have missed,” said Isaac Park, co-founder and CEO of Keebler Health. “The goal is to reduce provider risk and improve operational performance while improving patient outcomes.”